Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGM2 | P21980 | 1/20 | 0.60 |
| ▸ | HINT1 | P49773 | 1/20 | 0.58 |
| ▸ | KRAS | P01116 | 2/20 | 0.57 |
| ▸ | FUT5 | Q11128 | 1/20 | 0.57 |
| ▸ | FUT6 | P51993 | 4/20 | 0.55 |
| ▸ | NT5E | P21589 | 2/20 | 0.55 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.54 |
| ▸ | IMPDH1 | P20839 | 1/20 | 0.54 |
| ▸ | DCPS | Q96C86 | 1/20 | 0.54 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.54 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.54 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.53 |
| ▸ | P2RY4 | P51582 | 1/20 | 0.53 |
| ▸ | P2RY6 | Q15077 | 1/20 | 0.53 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.52 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26067670 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL26067623 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL18769057 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL18769186 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL18769131 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL26067553 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL18769113 | 0.90 | TGM2 (0.71) | TGM2HINT1KRASFUT5NT5E | |
| SCHEMBL26067669 | 0.86 | TGM2 (0.66) | TGM2KRASFUT5NT5EDCPS | |
| SCHEMBL26067627 | 0.86 | TGM2 (0.66) | TGM2KRASFUT5NT5EDCPS | |
| SCHEMBL13134414 | 0.86 | TGM2 (0.66) | TGM2HINT1KRASFUT5NT5E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023199261-A1 | RNA MOLECULE CONTAINING MODIFIED CAP ANALOGS AT THE 5 ' END, USE OF RNA MOLECULE IN IN VITRO PROTEIN OR PEPTIDE SYNTHESIS, RNA MOLECULE FOR USE IN MEDICINE, AND USE OF MODIFIED CAP ANALOGS FOR RNA CAPPING | UNIWERSYTET WARSZAWSKI (PL) | 2023-10-19 | — | — | WO | disclosed |